Plain-English translation of NCT06707402 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Parkinson Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a 24-week brisk walking program can help people with Parkinson's disease walk better and improve their overall health. Walking problems are one of the most bothersome symptoms for people with Parkinson's, and current medications have limited benefits. This study will compare three groups: people who do supervised group walks plus home walks, people who do home walks with support from a tracker and phone calls, and a control group.
Walking difficulties are a major problem for people with Parkinson's disease that often gets worse over time, and there are few medications that effectively treat this symptom. This trial is testing whether a simple, accessible approach like brisk walking—which people can do in their community—might be a better, safer alternative to help preserve walking ability.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to one of three groups for 24 weeks. One group attends supervised group walking sessions plus does walking at home; another gets an activity tracker and supportive phone calls to encourage home walking; and the third group receives education only. All participants complete physical and cognitive tests at the start, after 24 weeks, and at a follow-up visit. The study involves learning more about how walking training affects not just your walking, but also your mood, thinking, independence, and overall quality of life.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Denmark